-+ 0.00%
-+ 0.00%
-+ 0.00%

Gogin Capital fund invests in Oceanus Bio through share subscription

PUBT·11/17/2026 00:15:35
Listen to the news
Gogin Capital fund invests in Oceanus Bio through share subscription
  • Gogin Capital announced on Nov. 17, 2026, that its fund subscribed for Oceanus Bio shares through a third-party allotment.
  • Oceanus Bio holds exclusive development and commercialization rights in Japan and Asia for a CBD treatment targeting drug-resistant epilepsy.
  • The treatment uses chemically synthesized CBD, supporting consistent quality and purity; safety testing in healthy adults is underway.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Gogin Capital Co Ltd published the original content used to generate this news brief on November 17, 2026, and is solely responsible for the information contained therein.